Table 5.
Predictor factor | RR | 95% CI of RR | P value |
---|---|---|---|
Age | 0.986 | 0.965–1.007 | 0.188 |
Gender | 1.040 | 0.683–1.585 | 0.854 |
Histology | 1.048 | 0.604–1.818 | 0.867 |
ECOG PS | 0.210 | 0.111–0.399 | 0.000 |
Time between NSCLC and LM | 0.808 | 0.596–1.097 | 0.172 |
WBRT | 0.588 | 0.375–0.920 | 0.020 |
SC | 0.842 | 0.574–1.392 | 0.273 |
EGFR-TKIs | 0.215 | 0.125–0.371 | 0.000 |
ECOG PS, Eastern Cooperative Oncology Group performance status
EGFR-TKIs, epidermal growth factor receptor tyrosine kinase inhibitors
LM, leptomeningeal metastases
NSCLC, non-small cell lung cancer
RR, relative risk
SC, systemic chemotherapy
WBRT, whole brain radiotherapy.